Irritable Bowel Syndrome Trial, Recruiting NCT07149519 Sponsor: University of Sao Paulo Condition: Irritable Bowel Syndrome
Back to Irritable Bowel Syndrome

Irritable Bowel Syndrome Trial, Recruiting

NCT07149519
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman between 18 and 50 years old who wants to take part in this clinical trial
  • You are willing to participate voluntarily and are comfortable being randomly assigned to any one of the three treatment groups in the study
  • You agree to not participate in any other clinical trial at the same time as this one
  • You are willing to sign a consent form that has been approved by the relevant ethics committees

Who may not be able to join:

  • You have a serious or poorly managed health condition, such as malnutrition, diabetes requiring insulin, uncontrolled high blood pressure, lung disease, blood or liver disorders, advanced kidney disease, metabolic disorders, or a weakened immune system
  • You have a gut or digestive condition that causes symptoms similar to irritable bowel syndrome, such as Crohn's disease, ulcerative colitis, microscopic colitis, celiac disease, or lactose intolerance
  • You have endometriosis that will require surgery during the study period
  • You have a serious eating disorder such as bulimia, anorexia nervosa, or binge-eating disorder
  • You have regularly used any medication in the last 6 months that could interact with probiotics or gut bacteria, such as antibiotics, antifungals, antihistamines, probiotics, or medications for constipation or diarrhea
  • You already regularly eat a very healthy diet or follow a restrictive diet more than four days a week, as this could affect the study results
  • Your stool test results show abnormalities (confirm with trial site)
  • You are unable to take medication by mouth
  • You are currently pregnant or breastfeeding
  • You have a history of dependence on alcohol or drugs
  • You have smoked at any point in the last three years
  • You have a cognitive or mental health condition that would make it difficult to work with the research team

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 March 2025
Est. completion
30 June 2028

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

pain improvement

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov